HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure.
Saved in:
| Title: | HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure. |
|---|---|
| Authors: | Ow SY; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Kapp EA; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Tomasetig V; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Zalewski A; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Simmonds J; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Panousis C; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Wilson MJ; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Nash AD; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Pelzing M; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia. |
| Source: | MAbs [MAbs] 2023 Jan-Dec; Vol. 15 (1), pp. 2163459. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1942-0870 |
|---|---|
| DOI: | 10.1080/19420862.2022.2163459 |
